• A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent

  • Dec 14 2024
  • Length: 10 mins
  • Podcast

A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent

  • Summary

  • Send us a text

    https://www.onthepen.com/post/novo-nordisk-catalent-deal-approved

    Support the show

    Our Book Has Been Released!
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4

    DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!

    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen

    MORE COMMUNITY!
    📺 Watch Our Weekly Live Show: onthepen.tv
    🆕 Discord: https://discord.gg/u4Ea8qqP

    🤝 Visit Our Sponsor!
    GLP-1 Ro Body Plan: https://www.ro.co/otp
    Report The Shortage: https://www.ro.co/supply-tracker
    Does your insurance cover GLPs? https://www.ro.com/checker

    📲 Contact Me: dave@onthepen.com

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and...

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.